Clinical Trials in New York

Showing 20341-20360 of 22,668 trials

ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

NCT00004926

RATIONALE: ILX23-7553 may help solid tumor cells develop into normal cells. PURPOSE: Phase I trial to study the effectiveness of ILX23-7553 in treating patients who have solid tumors that have not responded to previous therapy.

Unspecified Adult Solid Tumor, Protocol Specific

Memorial Sloan Kettering Cancer CenterStarted Oct 1999

Newark, New Jersey, United States • New York, New York, United States

COMPLETED< 1 mile

Electromagnetic Tracking of Devices During Biopsy Procedures

NCT01403727

The purpose of the trial is to evaluate the differences between PercuNav assisted and unassisted biopsy in the areas of CT radiation dose, procedure time and biopsy accuracy. This prospective, randomized, controlled trial will compare the use of electromagnetic tracking and image guidance (CT) during biopsy procedures verses the typical CT image guided procedure alone.

Liver Tumors

Philips Healthcare50 participantsStarted Nov 2011

New York, New York, United States

TERMINATEDPhase 2< 1 mile

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

NCT01001923

Primary objective was to demonstrate the activity of REGN475/SAR164877 in reducing the pain associated with chronic pancreatitis. Secondary objectives were: * to assess the safety and tolerability of REGN475/SAR164877 in patients with chronic pancreatitis pain; * to characterize the pharmacokinetic, pharmacodynamic, and immunogenicity profiles of REGN475/SAR164877 in this population; * to measure the change in the total daily dose of rescue medications required.

Abdominal Pain Upper

Regeneron Pharmaceuticals15 participantsStarted Dec 2009

Arcadia, California, United States • Bell Gardens, California, United States • Monterey, California, United States +14 more locations

ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

Electromagnetic Tracking of Devices During Biopsy Procedures

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

Find Trials by Condition in New York

Quality of Life in Survivors of Gynecologic Cancer

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Treating Depression With Transcranial Direct Current Stimulation (tDCS)

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms

Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer